Müller, Berit Maria <br/><br/>
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression.  [electronic resource] 

 -  BMC cancer  Apr 2013 
 - 215 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/1471-2407-13-215  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--enzymology<br/>Carcinoma, Ductal, Breast--enzymology<br/>Carcinoma, Lobular--enzymology<br/>Disease Progression<br/>Female<br/>Histone Deacetylase 1--metabolism<br/>Histone Deacetylase 2--metabolism<br/>Histone Deacetylases--metabolism<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lymphatic Metastasis<br/>Middle Aged<br/>Neoplasm Grading<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Tissue Array Analysis